Technology News and Research

RSS

Lectures on DermaVir to be presented at International Conference on Nanosciences & Nanotechnologies

Julianna Lisziewicz, PhD, President of Genetic Immunity, a biopharmaceutical company developing nanomedicine-based immunotherapies, is an invited speaker at this week's 7th International Conference on Nanosciences & Nanotechnologies in Ouranoupolis Halkidiki, Greece. The conference gathers front-line researchers, scientists and industry experts specialized in nanotechnology applications. Leading experts such as Dr. Lisziewicz are invited to present lectures covering the latest research in this rapidly progressing field.

12 Jul 2010

Biogen Idec, Swedish Orphan Biovitrum present results from rFIXFc Phase 1/2a study in hemophilia B

Biogen Idec and Swedish Orphan Biovitrum AB today announced results from a Phase 1/2a open-label, dose-escalation, safety and pharmacokinetic study of the companies' long-lasting, fully-recombinant factor IX Fc fusion protein (rFIXFc) in hemophilia B patients. The data, which were presented at the World Federation of Hemophilia Congress in Buenos Aires, Argentina, on July 11, 2010, showed that rFIXFc was well tolerated and demonstrated an approximately three-fold increase in half-life compared to historical data for existing therapies.

12 Jul 2010

Vaccine manufacturers may be able to produce lower-cost HPV vaccines, say researchers

Vaccine manufacturers in India and other developing countries may be able to produce a lower-cost HPV vaccine in spite of the complicated array of patent protections on the technology, say researchers at the Duke Institute for Genome Sciences & Policy. At a cost of at least $300 for the three-dose regimen, the blockbuster HPV vaccines, including Gardasil- from Merck and Cervarix- from GlaxoSmithKline, are some of the most expensive ever introduced.

12 Jul 2010

Educational psychologists use eye-tracking method for detecting lies

Shifty eyes long have been thought to signify a person's problem telling the truth. Now a group of University of Utah researchers are taking that old adage to a new level.

12 Jul 2010

BRAIN AG acquires a minority share in Enzymicals AG

BRAIN AG, one of the leading European white biotechnology companies, has acquired a minority share in Enzymicals AG. This biotechnology company was founded in 2009 as a spin-off by a management team from the workgroup led by Prof. Dr. Uwe Bornscheuer from Ernst-Moritz-Arndt University Greifswald with support from the EXIST-Programme of the Federal Ministry for Economy and Technology.

12 Jul 2010

athenaClinicals Version 10.6 receives CCHIT's EHR technology, preliminary IFR Stage 1 certification

athenahealth, Inc., a leading provider of web-based practice management, electronic health record, and patient communication services to medical groups, today announced that the latest version of its web-based EHR service, athenaClinicalsSM Version 10.6, has been inspected by the Certification Commission for Health Information Technology (CCHIT®) and is certified EHR technology, IFR Stage 1, preliminarily meeting 24 of 24 requirements for Eligible Providers published by the U.S. Department of Health and Human Services (HHS) in the Interim Final Rule.

12 Jul 2010

Biogen Idec, Swedish Orphan Biovitrum announce advancement of rFVIIIFc into registrational study

Biogen Idec and Swedish Orphan Biovitrum today announced that they plan to advance the companies' long-lasting, fully-recombinant factor VIII Fc fusion protein (rFVIIIFc) into a registrational clinical trial in people with hemophilia A. The decision to advance the program is based on promising data from a Phase 1/2a open-label, cross-over, multi-center, dose-escalation study that evaluated the safety and pharmacokinetics of an intravenous injection of rFVIIIFc in 16 previously-treated patients with severe hemophilia A.

12 Jul 2010

Federal food safety agencies commended for supporting Food Safety Working Group

Agriculture Secretary Tom Vilsack and Secretary of Health and Human Services Kathleen Sebelius today commended federal food safety agencies for their accomplishments supporting the charge of President Obama's Food Safety Working Group, which advises the President on how to upgrade the U.S. food safety system for the 21st century.

12 Jul 2010

Vanderbilt Medical Center treats first patient in Galil Medical's new TRACE renal registry

Galil Medical, a global leader in minimally invasive cryotherapy cancer treatments, today announced that Vanderbilt University Medical Center in Nashville, Tenn., has treated the first patient to be included in its new patient registry.

12 Jul 2010

MRC Technology, Genentech sign licensing agreement

MRC Technology (UK) announced today that it has entered into an agreement with Genentech, Inc., a wholly owned member of the Roche Group for an exclusive licence to a series of small molecule drug candidates for the potential treatment of neurological disease.

12 Jul 2010

Mesoblast schedules formal meeting with FDA to discuss proposed Phase 3 clinical trial program

Australian regenerative medicine company, Mesoblast Limited, today announced that based on positive results from its bone marrow transplant clinical trial conducted at the University of Texas MD Anderson Cancer Center, a formal meeting has been scheduled with the United States Food and Drug Administration to discuss a proposed Phase 3 clinical trial program.

12 Jul 2010

Multimedia talking touchscreens help end health disparities in underserved populations

Multimedia talking touchscreens, housed in computer kiosks at clinics and hospitals, are helping researchers at Northwestern University Feinberg School of Medicine and clinicians at local health care centers enhance patient-centered care for patients with diverse language, literacy and computer skills.

12 Jul 2010

Sirtuin1 protein promotes memory, brain flexibility: MIT researchers

The same molecular mechanism that increases life span through calorie restriction may help boost memory and brainpower, researchers at MIT's Picower Institute for Learning and Memory report in the July 11 issue of Nature.

12 Jul 2010

Accelr8 Technology completes sale of non-exclusive license for OptiChem bio-coatings

Accelr8 Technology Corporation today announced that it completed the sale of a non-exclusive license for its proprietary OptiChem bio-coatings to an innovative, public diagnostics company. The licensee is paying $1,865,000 over four annual escalating payments and intends to use OptiChem® in its disposable diagnostic devices.

12 Jul 2010

UM researcher uses computer algorithms to develop vaccines for new strains of influenza viruses

Defeating the flu is challenging because the virus responsible for the disease undergoes frequent changes of its genetic code, making it difficult for scientists to manufacture effective vaccines for the seasonal flu in a timely manner. Now, a University of Miami computer scientist, Dimitris Papamichail, and a team of researchers from Stony Brook University have developed a rapid and effective approach to produce vaccines for new strains of influenza viruses.

9 Jul 2010

Pioneer Surgical Technology expands Biologics Product Specialist program

Pioneer Surgical Technology, Inc. recently expanded its Biologics Product Specialist program to provide sales and technical biologic expertise to support their growing line of products that address bone and soft tissue repair.

9 Jul 2010

HHS proposes stricter patient privacy rules

New rules have been proposed by the Department of Health and Human Services to stregthen patient privacy protections.

9 Jul 2010

Adimab announces initiation of research collaboration with Novartis

Adimab, Inc., a leader in the discovery of fully human antibodies, today announced the initiation of a research collaboration with Novartis (Basel, Switzerland). This agreement represents the fifth major partnership Adimab has announced since launching its platform at BIO 2009 in Atlanta, just one year ago. In addition, Adimab today announced the receipt of a second milestone payment from its ongoing collaboration with Merck and Co.

9 Jul 2010

Today's OpEds: More commentary on the Berwick appointment, the financial and political costs of health reform, thoughts on hospital consolidation

President Obama got serious this week about the ticking time bomb in his new health-care legislation -- the lack of any clear plan to reduce costs and improve quality. What he did was install someone who can use our behemoth Medicare and Medicaid programs as laboratories for change -- so that reform doesn't bankrupt the country (David Ignatius, 7/9).

9 Jul 2010

Tulane University to receive $11.2M over seven years to establish international malaria research center

Tulane University will receive approximately $11.2 million over seven years from the National Institute of Allergy and Infectious Diseases, a division of the National Institutes of Health, to establish an International Center of Excellence in Malaria Research for West and Central Africa. The money will be awarded in response to a multi-institutional proposal from Tulane University School of Public Health and Tropical Medicine.

9 Jul 2010

Technology News and Research

Lectures on DermaVir to be presented at International Conference on Nanosciences & Nanotechnologies

Biogen Idec, Swedish Orphan Biovitrum present results from rFIXFc Phase 1/2a study in hemophilia B

Vaccine manufacturers may be able to produce lower-cost HPV vaccines, say researchers

Educational psychologists use eye-tracking method for detecting lies

BRAIN AG acquires a minority share in Enzymicals AG

athenaClinicals Version 10.6 receives CCHIT's EHR technology, preliminary IFR Stage 1 certification

Biogen Idec, Swedish Orphan Biovitrum announce advancement of rFVIIIFc into registrational study

Federal food safety agencies commended for supporting Food Safety Working Group

Vanderbilt Medical Center treats first patient in Galil Medical's new TRACE renal registry

MRC Technology, Genentech sign licensing agreement

Mesoblast schedules formal meeting with FDA to discuss proposed Phase 3 clinical trial program

Multimedia talking touchscreens help end health disparities in underserved populations

Sirtuin1 protein promotes memory, brain flexibility: MIT researchers

Accelr8 Technology completes sale of non-exclusive license for OptiChem bio-coatings

UM researcher uses computer algorithms to develop vaccines for new strains of influenza viruses

Pioneer Surgical Technology expands Biologics Product Specialist program

HHS proposes stricter patient privacy rules

Adimab announces initiation of research collaboration with Novartis

Today's OpEds: More commentary on the Berwick appointment, the financial and political costs of health reform, thoughts on hospital consolidation

Tulane University to receive $11.2M over seven years to establish international malaria research center

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News